Shandong Wohua Pharmaceutical Hits Day High with 10.07% Surge

Shandong Wohua Pharmaceutical Co., Ltd. has experienced a significant surge in its stock price, gaining 10.07% on April 9, 2026. The stock reached an intraday high of CNY 7.65, marking a notable performance against the backdrop of the China Shanghai Composite, which declined by 0.72% on the same day. Over the past week, Shandong Wohua has shown a robust performance with a 12.33% increase, while its one-month performance stands at 9.91%. Impressively, the stock has delivered an 87.04% return over the past year, significantly outperforming the China Shanghai Composite's 24.46% gain. Financial metrics indicate a strong position for the company, with a net profit growth of 64.2% reported in December 2025. The company boasts a return on equity (ROE) of 12.27% and a price-to-book ratio of 5.59. Additionally, the debt equity ratio is notably low at -0.54, reflecting a solid financial foundation. As a small-cap player in the pharmaceuticals and biotechnology sector, Shandong Wohua continues to demonstrate market-beating performance, underscoring its potential within the industry.